This compound is a pharmaceutical intermediate featuring a complex oxolane ring substituted with trifluoromethyl, difluoromethoxyphenyl, and pyridinecarboxamide groups. It is primarily utilized as a building block in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2649467-57-0
Suzetrigine Impurity 13
active pharmaceutical ingredient impurity
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid
pharmaceutical intermediate
N-Carbobenzoxy-L-glutamine
protected amino acid intermediate
(2S)-1-methoxypropan-2-ol
Pharmaceutical intermediate for olmesartan medoxomil
3-amino-N-(4-aminophenyl)benzamide
pharmaceutical intermediate
Suzetrigine
sodium channel blocker
4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carbonyl]amino]pyridine-2-carboxamide
XSQUJFKRXZMOKA-BHFKVQLUSA-N
C[C@@H]1[C@@H]([C@H](O[C@]1(C)C(F)(F)F)C(=O)NC2=CC(=NC=C2)C(=O)N)C3=C(C(=C(C=C3)F)F)OC